首页 | 本学科首页   官方微博 | 高级检索  
检索        


Use of recommended medications after myocardial infarction in Austria
Authors:Wolfgang C Winkelmayer  Anna E Bucsics  Alexandra Schautzer  Peter Wieninger  Michaela Pogantsch  for the Pharmacoeconomics Advisory Council of the Austrian Sickness Funds
Institution:Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, USA. wwinkelmayer@partners.org
Abstract:
Keywords:Myocardial infarction  Statins  Beta-blockers  Angiotensin converting enzyme inhibitors  Angiotensin receptor blockers  Secondary prevention
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号